Literature DB >> 8099565

Primary human adult lung epithelial cells in vitro: response to interferon-gamma and cytomegalovirus.

L Ibrahim1, M Dominguez, M Yacoub.   

Abstract

Primary human adult lung epithelial cells (ALEC) were established in culture using the most distal parts of the lung to avoid the airways. Immunocytochemical peroxidase staining and semiquantitative flow cytometry were used to characterize the cells in conjunction with a panel of monoclonal antibodies (mAb). The cells showed a constitutive expression of major histocompatibility complex (MHC) class I antigens, patchy expression of intercellular adhesion molecule-1 (ICAM-1) and a weak patchy expression of MHC class II antigens (detected using immunocytochemical staining). Incubation of the primary ALEC with interferon-gamma (IFN-gamma) (250 U/ml) stimulated an up-regulation of the expression of these three antigens to varying degrees; expression of MHC class I antigens and ICAM-1 molecules showed an up-regulation at 10 hr after the start of the treatment, reaching a peak at 48 hr, maintaining it for the next 24 hr and then, steadily and progressively, losing it towards the end of the experiment at 96 hr. Expression of HLA-DR showed an up-regulation at 17 hr after the start of the treatment, reaching a peak at 72 hr and maintaining it for the next 24 hr. Cytomegalovirus (CMV) infection of ALEC in culture caused an up-regulation of expression of class I antigens and ICAM-1, but not DR. However, when the infected cells were incubated with IFN-gamma, an up-regulation in the expression of DR took place. Therefore, within the micro-environment of the transplanted lung the presence of cytokines (IFN-gamma) produced by infiltrating activated mononuclear cells, may render the lung epithelial cells capable of acting as antigen-presenting cells, expressing high levels of class I antigens, ICAM-1 and class II antigens, activating CD8 and CD4 cells thus playing a major part in the process of rejection of the lung allograft; themselves becoming a primary target in the process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099565      PMCID: PMC1422047     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Expression of class I and class II major histocompatibility antigens in normal and transplanted human heart.

Authors:  M L Rose; M I Coles; R J Griffin; A Pomerance; M H Yacoub
Journal:  Transplantation       Date:  1986-06       Impact factor: 4.939

2.  Antibody to prekeratin. Decoration of tonofilament like arrays in various cells of epithelial character.

Authors:  W W Franke; K Weber; M Osborn; E Schmid; C Freudenstein
Journal:  Exp Cell Res       Date:  1978-10-15       Impact factor: 3.905

3.  Diagnosis and reversal of rejection in experimental and clinical lung allografts.

Authors:  F J Veith; S K Koerner; S S Siegelman; M Kawakami; S Kaufman; L A Attai; J W Hagstrom; M L Gliedman
Journal:  Ann Thorac Surg       Date:  1973-08       Impact factor: 4.330

4.  Nature and evolution of lung allograft rejection with and without immunosuppression.

Authors:  F J Veith; S B Sinha; S Blümcke; J C Dougherty; N H Becker; S S Siegelman; J W Hagstrom
Journal:  J Thorac Cardiovasc Surg       Date:  1972-04       Impact factor: 5.209

Review 5.  Lung transplantation 1983.

Authors:  F J Veith; S L Kamholz; F P Mollenkopf; C M Montefusco
Journal:  Transplantation       Date:  1983-04       Impact factor: 4.939

6.  Twenty-eight cases of human heart-lung transplantation.

Authors:  C M Burke; J Theodore; J C Baldwin; H D Tazelaar; A J Morris; C McGregor; N E Shumway; E D Robin; S W Jamieson
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

7.  Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation.

Authors:  C M Burke; J Theodore; K D Dawkins; S A Yousem; N Blank; M E Billingham; A Van Kessel; S W Jamieson; P E Oyer; J C Baldwin
Journal:  Chest       Date:  1984-12       Impact factor: 9.410

8.  A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1.

Authors:  R Rothlein; M L Dustin; S D Marlin; T A Springer
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

9.  Expression of HLA antigens on renal tubular cells in culture. I. Evidence that mixed lymphocyte culture supernatants and gamma interferon increase both class I and class II HLA antigens.

Authors:  G A Bishop; B M Hall; M G Suranyi; D J Tiller; J S Horvath; G G Duggin
Journal:  Transplantation       Date:  1986-12       Impact factor: 4.939

10.  Interstitial mononuclear cell populations in renal graft rejection. Identification by monoclonal antibodies in tissue sections.

Authors:  J L Platt; T W LeBien; A F Michael
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.

Authors:  Deborah M Brown
Journal:  Cell Immunol       Date:  2010-02-24       Impact factor: 4.868

2.  Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model.

Authors:  Marguerite R Kelher; Anirban Banerjee; Fabia Gamboni; Cameron Anderson; Christopher C Silliman
Journal:  Transfusion       Date:  2016-09-25       Impact factor: 3.157

3.  Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/CD18-mediated interactions with neutrophils.

Authors:  C A Parkos; S P Colgan; M S Diamond; A Nusrat; T W Liang; T A Springer; J L Madara
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

Review 4.  Intercellular adhesion molecule-1.

Authors:  A van de Stolpe; P T van der Saag
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

5.  Porcine cytomegalovirus infection is associated with early rejection of kidney grafts in a pig to baboon xenotransplantation model.

Authors:  Kazuhiko Yamada; Masayuki Tasaki; Mitsuhiro Sekijima; Robert A Wilkinson; Vincenzo Villani; Shannon G Moran; Taylor A Cormack; Isabel M Hanekamp; Robert J Hawley; J Scott Arn; Jay A Fishman; Akira Shimizu; David H Sachs
Journal:  Transplantation       Date:  2014-08-27       Impact factor: 4.939

Review 6.  CD4 CTL: living up to the challenge.

Authors:  Hilde Cheroutre; Mohammad Mushtaq Husain
Journal:  Semin Immunol       Date:  2013-11-15       Impact factor: 11.130

7.  Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival.

Authors:  Chun-Hui Zhou; Li-Ping Ye; Shi-Xing Ye; Yan Li; Xin-Yin Zhang; Xin-Yu Xu; Li-Yun Gong
Journal:  J Exp Clin Cancer Res       Date:  2012-03-03

8.  Recipient iNOS but not eNOS deficiency reduces luminal narrowing in tracheal allografts.

Authors:  Kanji Minamoto; David J Pinsky
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307

9.  URGCP promotes non-small cell lung cancer invasiveness by activating the NF-κB-MMP-9 pathway.

Authors:  Junchao Cai; Rong Li; Xiaonan Xu; Le Zhang; Shanshan Wu; Tianyou Yang; Lishan Fang; Jueheng Wu; Xun Zhu; Mengfeng Li; Yongbo Huang
Journal:  Oncotarget       Date:  2015-11-03

Review 10.  Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory Tracts.

Authors:  Jonathan E Wosen; Dhriti Mukhopadhyay; Claudia Macaubas; Elizabeth D Mellins
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.